This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Roee Vidavski: Innovator in Antibacterial Compounds
Introduction
Roee Vidavski is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of antibacterial treatments through his innovative research and development efforts. His work focuses on novel compounds that target bacterial infections, showcasing his commitment to advancing medical science.
Latest Patents
Roee Vidavski holds a patent for "Compounds for treating bacterial infections - Rel proteins as a novel therapeutic agent for treating bacterial threats." This patent describes a novel class of compounds that possess antibacterial activity and inhibit the synthetic activity of RelA, RelSeq, or RelSpo, as well as bacterial spore formation. The patent also includes pharmaceutical compositions of these compounds and outlines a method for combating bacteria or treating bacterial infections by administering these compounds or compositions to individuals in need.
Career Highlights
Throughout his career, Roee has been associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore and develop groundbreaking solutions in the realm of bacterial infection treatment.
Collaborations
Roee Vidavski has collaborated with notable colleagues, including Ezequiel Wexselblatt and Joshua Katzhendler. These partnerships have further enriched his research and contributed to the advancement of his innovative projects.
Conclusion
Roee Vidavski's contributions to the field of antibacterial compounds highlight his role as a significant inventor in medical research. His innovative approaches and collaborations continue to pave the way for advancements in treating bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
